164 related articles for article (PubMed ID: 32302613)
41. Autoantibodies and CD: past and future of celiac antibody testing.
Korponay-Szabó IR
J Pediatr Gastroenterol Nutr; 2014 Jul; 59 Suppl 1():S11-3. PubMed ID: 24979192
[TBL] [Abstract][Full Text] [Related]
42. The analysis of the fine specificity of celiac disease antibodies using tissue transglutaminase fragments.
Sblattero D; Florian F; Azzoni E; Zyla T; Park M; Baldas V; Not T; Ventura A; Bradbury A; Marzari R
Eur J Biochem; 2002 Nov; 269(21):5175-81. PubMed ID: 12392549
[TBL] [Abstract][Full Text] [Related]
43. Molecular dissection of the tissue transglutaminase autoantibody response in celiac disease.
Marzari R; Sblattero D; Florian F; Tongiorgi E; Not T; Tommasini A; Ventura A; Bradbury A
J Immunol; 2001 Mar; 166(6):4170-6. PubMed ID: 11238668
[TBL] [Abstract][Full Text] [Related]
44. Gluten: a two-edged sword. Immunopathogenesis of celiac disease.
Koning F; Gilissen L; Wijmenga C
Springer Semin Immunopathol; 2005 Sep; 27(2):217-32. PubMed ID: 16091925
[TBL] [Abstract][Full Text] [Related]
45. Intestinal tissue transglutaminase in coeliac disease of children and adults: ultrastructural localization and variation in expression.
Skovbjerg H; Hansen GH; Niels-Christiansen LL; Anthonsen D; Ascher H; Midhagen G; Hallert C; Norén O; Sjöström H
Scand J Gastroenterol; 2004 Dec; 39(12):1219-27. PubMed ID: 15742999
[TBL] [Abstract][Full Text] [Related]
46. Transglutaminase, gluten and celiac disease: food for thought. Transglutaminase is identified as the autoantigen of celiac disease.
Marsh MN
Nat Med; 1997 Jul; 3(7):725-6. PubMed ID: 9212095
[No Abstract] [Full Text] [Related]
47. Clinical and Immunologic Features of Ultra-Short Celiac Disease.
Mooney PD; Kurien M; Evans KE; Rosario E; Cross SS; Vergani P; Hadjivassiliou M; Murray JA; Sanders DS
Gastroenterology; 2016 May; 150(5):1125-1134. PubMed ID: 26836585
[TBL] [Abstract][Full Text] [Related]
48. Gluten-dependent intestinal autoimmune response.
Korponay-Szabó IR; Simon-Vecsei Z; De Leo L; Not T
Curr Pharm Des; 2012; 18(35):5753-8. PubMed ID: 22726113
[TBL] [Abstract][Full Text] [Related]
49. Tissue transglutaminase in celiac disease: role of autoantibodies.
Caputo I; Barone MV; Martucciello S; Lepretti M; Esposito C
Amino Acids; 2009 Apr; 36(4):693-9. PubMed ID: 18600381
[TBL] [Abstract][Full Text] [Related]
50. The pathogenesis of coeliac disease.
Dewar D; Pereira SP; Ciclitira PJ
Int J Biochem Cell Biol; 2004 Jan; 36(1):17-24. PubMed ID: 14592529
[TBL] [Abstract][Full Text] [Related]
51. The roles of MHC class II genes and post-translational modification in celiac disease.
Sollid LM
Immunogenetics; 2017 Aug; 69(8-9):605-616. PubMed ID: 28695286
[TBL] [Abstract][Full Text] [Related]
52. Celiac disease-related autoantibodies in end-stage autoimmune liver diseases: what is the message?
Dalekos GN; Bogdanos DP; Neuberger J
Liver Int; 2008 Apr; 28(4):426-8. PubMed ID: 18339068
[No Abstract] [Full Text] [Related]
53. Biomedicine. Gluten and the gut-lessons for immune regulation.
Schuppan D; Hahn EG
Science; 2002 Sep; 297(5590):2218-20. PubMed ID: 12351776
[No Abstract] [Full Text] [Related]
54. Celiac disease and transglutaminase 2: a model for posttranslational modification of antigens and HLA association in the pathogenesis of autoimmune disorders.
Sollid LM; Jabri B
Curr Opin Immunol; 2011 Dec; 23(6):732-8. PubMed ID: 21917438
[TBL] [Abstract][Full Text] [Related]
55. Unexpected role of surface transglutaminase type II in celiac disease.
Maiuri L; Ciacci C; Ricciardelli I; Vacca L; Raia V; Rispo A; Griffin M; Issekutz T; Quaratino S; Londei M
Gastroenterology; 2005 Nov; 129(5):1400-13. PubMed ID: 16285941
[TBL] [Abstract][Full Text] [Related]
56. Coeliac disease: dissecting a complex inflammatory disorder.
Sollid LM
Nat Rev Immunol; 2002 Sep; 2(9):647-55. PubMed ID: 12209133
[TBL] [Abstract][Full Text] [Related]
57. Reduction of tissue transglutaminase autoantibody levels by gluten-free diet is associated with changes in subsets of peripheral blood lymphocytes in children with newly diagnosed coeliac disease.
Agardh D; Lynch K; Brundin C; Ivarsson SA; Lernmark A; Cilio CM
Clin Exp Immunol; 2006 Apr; 144(1):67-75. PubMed ID: 16542367
[TBL] [Abstract][Full Text] [Related]
58. Intestinal Production of Anti-Tissue Transglutaminase 2 Antibodies in Patients with Diagnosis Other Than Celiac Disease.
Maglio M; Ziberna F; Aitoro R; Discepolo V; Lania G; Bassi V; Miele E; Not T; Troncone R; Auricchio R
Nutrients; 2017 Sep; 9(10):. PubMed ID: 28934109
[TBL] [Abstract][Full Text] [Related]
59. Direct cloning and tetramer staining to measure the frequency of intestinal gluten-reactive T cells in celiac disease.
Bodd M; Ráki M; Bergseng E; Jahnsen J; Lundin KE; Sollid LM
Eur J Immunol; 2013 Oct; 43(10):2605-12. PubMed ID: 23775608
[TBL] [Abstract][Full Text] [Related]
60. IgA-class transglutaminase antibodies in evaluating the efficacy of gluten-free diet in coeliac disease.
Kaukinen K; Sulkanen S; Mäki M; Collin P
Eur J Gastroenterol Hepatol; 2002 Mar; 14(3):311-5. PubMed ID: 11953698
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
